Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3058971000168119 | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3058981000168116 | Xylocard 2% (100 mg/5 mL) injection, 5 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Is a | Xylocard | true | Inferred relationship | Some | ||
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Is a | lidocaine hydrochloride 2% (100 mg/5 mL) injection, ampoule | true | Inferred relationship | Some | ||
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | has unit of use | ampoule | true | Inferred relationship | Some | 2135347771 | |
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 2135347770 | |
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | has Australian BoSS | lidocaine hydrochloride | true | Inferred relationship | Some | 2135347770 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Xylocard 2% (100 mg/5 mL) injection, 5 mL ampoule | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Xylocard 2% (100 mg/5 mL) injection, 2 x 5 mL ampoules | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Xylocard 2% (100 mg/5 mL) injection, 5 mL ampoule | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Xylocard 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Xylocard 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Xylocard 2% (100 mg/5 mL) injection, 2 x 5 mL ampoules | has TPUU | True | Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set